Evan Thomas Hall

10PUBLICATIONS
98CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 19, 2025
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en, Yuzheng Zhang, Daniel S Hippe

|Jul 29, 2025
Sonographic Signatures of Immune Checkpoint Inhibitor-Associated Musculoskeletal Adverse Events.

Hans Vitzthum von Eckstaedt, Kevin Weng, Ingeborg Sacksen

|Jul 07, 2025
A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH).

Wenwen Chen, Julia Majovski, Shailender Bhatia

|Jul 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.

Tomoko Akaike, Manisha Thakuria, Ann W Silk

|Jul 29, 2023
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.

Andrew B Barbour, Simon Kirste, Anca-Liga Grosu

|May 16, 2023
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Talal El Zarif, Amin H Nassar, Elio Adib

Pageof 2

Frequent Collaborators

3 joint publications

Tomoko Akaike

3 joint publications

Daniel S Hippe

3 joint publications

Paul Nghiem

2 joint publications

Shailender Bhatia